Evolent Health (EVH) Current Deferred Revenue (2015 - 2026)

Evolent Health's Current Deferred Revenue history runs 12 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 71.76% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 71.76% YoY), while the FY2025 annual figure was $1.2 million, down 52.01% from the prior year.
• Current Deferred Revenue was $1.4 million for Q1 2026 at Evolent Health, up from $1.2 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $13.3 million in Q1 2022 to a low of $1.2 million in Q4 2025.
• Historically, Current Deferred Revenue has averaged $5.9 million across 5 years, with a median of $5.8 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Current Deferred Revenue gained 3.79% in 2023, then slumped 71.76% in 2026.
• A 5-year view of Current Deferred Revenue shows it stood at $5.8 million in 2022, then grew by 3.79% to $6.0 million in 2023, then tumbled by 58.05% to $2.5 million in 2024, then sank by 52.01% to $1.2 million in 2025, then advanced by 17.79% to $1.4 million in 2026.
• The last three Current Deferred Revenue figures came in at $1.4 million (Q1 2026), $1.2 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.